FDAFDA · Food and drugs·Recall number D-0511-2024
Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64
Published June 5, 2024 · Recall initiated: April 20, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate
What to do
Voluntary: Firm initiated · Telephone
Recall details
- Manufacturer
- Revive Rx LLC dba Revive Rx Pharmacy
- Distributor
- USA Nationwide
- Lot
- Lot #: 748127, Exp 9/24/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.